Page 11 - Device Designation News Today

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

/PRNewswire/ -- Biological Dynamics, a company developing its exosome-isolation ExoVerita™ platform for early disease diagnostics, announced today it has...

Study to demonstrate its proprietary tests effectiveness for early detection of pancreatic cancerSAN DIEGO, Dec. 1, 2022 /PRNewswire/ -- Biologic...